Quality Strategy Sample Clauses

The Quality Strategy clause defines the standards and processes that must be followed to ensure the quality of goods or services provided under the agreement. It typically outlines the specific quality benchmarks, methods of monitoring and assessment, and responsibilities for maintaining these standards throughout the contract term. By establishing clear expectations and procedures, this clause helps prevent disputes over quality, ensures consistent performance, and provides a framework for addressing any deficiencies that may arise.
POPULAR SAMPLE Copied 1 times
Quality Strategy. The state must adopt and implement a comprehensive and holistic, continuous quality improvement strategy that focuses on all aspects of quality improvement in the demonstration. The state may do this by either: (1) modifying its existing Quality strategy or (2) creating an additional, CMO-specific quality strategy. The Quality Strategy must include the quality measures tied to incentive payments under the CMO contract, which must in turn reflect the strategic goals of the demonstration. The state must revise its Quality Strategy whenever significant changes are made, including changes through this demonstration. The state must obtain the input of beneficiaries and other stakeholders in the development of its Quality Strategy and make the Strategy available for public comment. Pursuant to STC 56, the state must also provide CMS with annual reports on the implementation and effectiveness of its Quality Strategy as it impacts the demonstration. a. Within 30 days of approval, the state must notify CMS of its decision regarding whether to modify its existing Quality Strategy or to create an additional Quality Strategy to address CMO quality. b. The state must submit its draft Quality Strategy within 60 days from the start date of the CMO contract. CMS will review this strategy and provide comments to the state. The state must then revise the Quality Strategy, taking into account and responding to CMS feedback, and submit a revised version within 45 days of receipt of CMS comments. c. The state must inform CMS in its annual report (STC 56) or in the bimonthly monitoring calls (STC 54) of any anticipated changes to the Quality Strategy. All revisions to the quality strategy must be submitted to CMS at least 60 days prior to implementation for review and comment. A final revised version, taking into consideration CMS feedback, must be submitted to CMS within 45 days of receipt of CMS feedback.
Quality Strategy. Pursuant to STC 37, the state must report on the implementation and effectiveness of the updated Comprehensive Quality Strategy as it impacts the demonstration;

Related to Quality Strategy

  • Quality Assurance The parties endorse the underlying principles of the Company’s Quality Management System, which seeks to ensure that its services are provided in a manner which best conforms to the requirements of the contract with its customer. This requires the Company to establish and maintain, implement, train and continuously improve its procedures and processes, and the employees to follow the procedures, document their compliance and participate in the improvement process. In particular, this will require employees to regularly and reliably fill out documentation and checklists to signify that work has been carried out in accordance with the customer’s specific requirements. Where necessary, training will be provided in these activities.

  • Quality Management Grantee will: 1. comply with quality management requirements as directed by the System Agency. 2. develop and implement a Quality Management Plan (QMP) that conforms with 25 TAC § 448.504 and make the QMP available to System Agency upon request. The QMP must be developed no later than the end of the first quarter of the Contract term. 3. update and revise the QMP each biennium or sooner, if necessary. ▇▇▇▇▇▇▇’s governing body will review and approve the initial QMP, within the first quarter of the Contract term, and each updated and revised QMP thereafter. The QMP must describe ▇▇▇▇▇▇▇’s methods to measure, assess, and improve - i. Implementation of evidence-based practices, programs and research-based approaches to service delivery; ii. Client/participant satisfaction with the services provided by ▇▇▇▇▇▇▇; iii. Service capacity and access to services; iv. Client/participant continuum of care; and v. Accuracy of data reported to the state. 4. participate in continuous quality improvement (CQI) activities as defined and scheduled by the state including, but not limited to data verification, performing self-reviews; submitting self-review results and supporting documentation for the state’s desk reviews; and participating in the state’s onsite or desk reviews. 5. submit plan of improvement or corrective action plan and supporting documentation as requested by System Agency. 6. participate in and actively pursue CQI activities that support performance and outcomes improvement. 7. respond to consultation recommendations by System Agency, which may include, but are not limited to the following: i. Staff training; ii. Self-monitoring activities guided by System Agency, including use of quality management tools to self-identify compliance issues; and iii. Monitoring of performance reports in the System Agency electronic clinical management system.

  • Quality Assurance Program An employee shall be entitled to leave of absence without loss of earnings from her or his regularly scheduled working hours for the purpose of writing examinations required by the College of Nurses of Ontario arising out of the Quality Assurance Program.

  • Program Development NWESD agrees that priority in the development of new applications services by WSIPC shall be in accordance with the expressed direction of the WSIPC Board of Directors operating under their bylaws.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.